Terms: = Lymphoma AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580
376 results:
1. The Complexity of Being a20: From Biological Functions to Genetic Associations.
Karri U; Harasimowicz M; Carpio Tumba M; Schwartz DM
J Clin Immunol; 2024 Mar; 44(3):76. PubMed ID: 38451381
[TBL] [Abstract] [Full Text] [Related]
2. Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments.
Krull JE; Wenzl K; Hopper MA; Manske MK; Sarangi V; Maurer MJ; Larson MC; Mondello P; Yang Z; Novak JP; Serres M; Whitaker KR; Villasboas Bisneto JC; Habermann TM; Witzig TE; Link BK; Rimsza LM; King RL; Ansell SM; Cerhan JR; Novak AJ
Cell Rep Med; 2024 Mar; 5(3):101443. PubMed ID: 38428430
[TBL] [Abstract] [Full Text] [Related]
3. Lung carcinoma with diffuse cysts repeatedly misdiagnosed as pulmonary infections and lymphoid interstitial pneumonia: A case report.
Li Y; Lu J; Yuan J
Medicine (Baltimore); 2024 Feb; 103(5):e37002. PubMed ID: 38306516
[TBL] [Abstract] [Full Text] [Related]
4. Primary central nervous system marginal zone lymphoma.
Flospergher E; Marino F; Calimeri T; Cangi MG; Ferreri AJM; Ponzoni M; Bongiovanni L
Br J Haematol; 2024 Jan; 204(1):31-44. PubMed ID: 38054330
[TBL] [Abstract] [Full Text] [Related]
5. A non-small cell lung carcinoma patient responded to crizotinib therapy after alectinib-induced interstitial lung disease.
Sun W; Zheng J; Zhou J; Zhou J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 52(5):583-587. PubMed ID: 37899398
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement.
Geng H; Jia S; Zhang Y; Li J; Yang Q; Zeng L; Zong X; Lu Y; Lu S; Zhou J; Li C; Wu D
Front Immunol; 2023; 14():1219167. PubMed ID: 37671152
[TBL] [Abstract] [Full Text] [Related]
8. Identification of a novel RSRC1-ALK (R6: a20) fusion using next-generation sequencing technique.
Xia J; Chen S; Zhang Z; Wang J
Cancer Genet; 2023 Nov; 278-279():18-23. PubMed ID: 37572583
[TBL] [Abstract] [Full Text] [Related]
9. The Prevalence of MYD88 L265P and tnfaip3 Mutations and Their Correlations with Clinico-Hematological Profile in Egyptian Patients with Diffuse Large B Cell lymphoma.
Elbaz O; Shaat RM; Abd El Ghaffar HA; Shamaa S; Abdel-Masseih HM; Anber N; Mortada MI
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2485-2491. PubMed ID: 37505783
[TBL] [Abstract] [Full Text] [Related]
10. TIGIT is a key inhibitory checkpoint receptor in lymphoma.
Godfrey J; Chen X; Sunseri N; Cooper A; Yu J; Varlamova A; Zarubin D; Popov Y; Jacobson C; Postovalova E; Xiang Z; Nomie K; Bagaev A; Venkataraman G; Zha Y; Tumuluru S; Smith SM; Kline JP
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37364933
[TBL] [Abstract] [Full Text] [Related]
11. Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma.
Song Z; Wu W; Wei W; Xiao W; Lei M; Cai KQ; Huang DW; Jeong S; Zhang JP; Wang H; Kadin ME; Waldmann TA; Staudt LM; Nakagawa M; Yang Y
Blood; 2023 Oct; 142(15):1297-1311. PubMed ID: 37339580
[TBL] [Abstract] [Full Text] [Related]
12. Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas.
Hopper MA; Wenzl K; Hartert KT; Krull JE; Dropik AR; Novak JP; Manske MK; Serres MR; Sarangi V; Larson MC; Maurer MJ; Yang ZZ; Paludo J; McPhail ED; Habermann TM; Link BK; Rimsza LM; Ansell SM; Cerhan JR; Jevremovic D; Novak AJ
Hematol Oncol; 2023 Oct; 41(4):644-654. PubMed ID: 37254453
[TBL] [Abstract] [Full Text] [Related]
13. [Ceritinib as First-line Treatment for Advanced Lung Adenocarcinoma
with COX7A2L-ALK Fusion: A Case Report and Literature Review].
Yuan J; Pan R; Zhong W; Wang M
Zhongguo Fei Ai Za Zhi; 2023 Apr; 26(4):319-324. PubMed ID: 37183647
[TBL] [Abstract] [Full Text] [Related]
14. Function and targeting of MALT1 paracaspase in cancer.
O'Neill TJ; Tofaute MJ; Krappmann D
Cancer Treat Rev; 2023 Jun; 117():102568. PubMed ID: 37126937
[TBL] [Abstract] [Full Text] [Related]
15. Effects of Vinblastine and Vincristine on the function of chronic myeloid leukemic cells through expression of a20 and CYLD.
Hoang NH; Huyen NT; Trang DT; Canh NX; Mao CV; Sopjani M; Vuong NB; Xuan NT
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):47-53. PubMed ID: 37114273
[TBL] [Abstract] [Full Text] [Related]
16. Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP Workshop.
Nejati R; Amador C; Czader M; Thacker E; Thakkar D; Dave SS; Dogan A; Duffield A; Goodlad JR; Ott G; Wasik MA; Xiao W; Cook JR
Am J Clin Pathol; 2023 Jun; 159(6):598-613. PubMed ID: 37085150
[TBL] [Abstract] [Full Text] [Related]
17. Deciphering the spectrum of cutaneous lymphomas expressing TFH markers.
Donzel M; Trecourt A; Balme B; Harou O; Mauduit C; Bachy E; Guesquières H; Fontaine J; Ortonne N; Perier-Muzet M; Dalle S; Traverse-Glehen A
Sci Rep; 2023 Apr; 13(1):6500. PubMed ID: 37081015
[TBL] [Abstract] [Full Text] [Related]
18. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
[TBL] [Abstract] [Full Text] [Related]
19. Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia.
Wang X; Chen C; Vuong D; Rodriguez-Rodriguez S; Lam V; Roleder C; Wang JH; Kambhampati S; Berger A; Pennock N; Torka P; Hernandez-Ilizaliturri F; Siddiqi T; Wang L; Xia Z; Danilov AV
Leukemia; 2023 Jun; 37(6):1324-1335. PubMed ID: 37031300
[TBL] [Abstract] [Full Text] [Related]
20. HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models.
Ke H; Zhang F; Wang J; Xiong L; An X; Tu X; Chen C; Wang Y; Mao B; Guo S; Ju C; He X; Sun R; Zhang L; O'Connor OA; Li QX
Sci Rep; 2023 Apr; 13(1):5419. PubMed ID: 37012357
[TBL] [Abstract] [Full Text] [Related]
[Next]
